Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SURP and G-patch domain-containing protein 1 (SUGP1) is a nuclear RNA-binding protein characterized by the presence of SURP domains and a G-patch domain, which are important for interactions with other splicing factors and RNA helicases[1][3]. SUGP1 plays a crucial role in pre-mRNA splicing, specifically involved in the selection of branch sites during the early assembly of the spliceosome. It acts as a molecular adaptor, interacting with the splicing factor SF3B1 and the DEAH-box RNA helicase DHX15. Mutations in either SUGP1 or SF3B1 disrupt this interaction, leading to aberrant RNA splicing patterns, a hallmark mechanism implicated in the development of myeloid malignancies and certain solid tumors[1][3][4]. SUGP1 is not currently recognized as a direct therapeutic target or receptor but is an essential part of the human spliceosome regulatory machinery, with its dysfunction contributing to oncogenic splicing programs in cancer. - SUGP1 mutations or disturbed interactions can recapitulate the splicing defects observed in SF3B1-mutated cancers[1][3][4]. - The C-terminal region of SUGP1 is especially critical for its interactions with SF3B1 and DHX15[1][3]. - SUGP1 is not known to interact directly with any approved drugs or to act in a manner that would make it a classic drug target[1][3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SURP and G-patch domain-containing protein 1 (SUGP1).